Europe improves oversight of medicines (blog)
“It's a shame that it often takes a scandal to bring about higher standards in legislation,” says rapporteur Linda McAvan, British Socialist and Democrat (S&D) MEP. The updated rules “will have no impact on the initial authorization process, but
EU to get better safety monitoring of dangerous drugsEurActiv

all 2 news articles »